Viagra, Cialis Defendants Get Judgment in Skin Cancer MDL

Pfizer Inc. and Eli Lilly & Co. won final judgment from the Northern District of California in multidistrict litigation alleging Viagra and Cialis increase the risk of skin cancer, following the court’s earlier exclusion of the plaintiffs’ expert witnesses.

The U.S. District Court for the Northern District of California granted the defendants’ unopposed motion for summary judgment, paving the way for the plaintiffs to appeal the evidentiary ruling.

Plaintiffs alleged they suffered from melanoma exacerbated by their use of Pfizer’s drug Viagra and Lilly’s drug Cialis.

But the court barred their general causation experts in January. It said the experts’ ...